METHOD OF TREATING PATIENTS WITH ORAL MUCOSAL PARESTHESIA WITH UNDERLYING HYPERACID GASTRITIS Russian patent published in 2014 - IPC A61K31/425 A61P1/04 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely dentistry. The presence of a pseudoallergic component is determined in a patient with oral mucosal paresthesia with underlying hyperacid gastritis by determining blood and oral histamine, as well as total blood immunoglobulin E. If observing an increase of blood and oral histamine as compared to reference values, as well as a reference total blood immunoglobulin E that testifies to the presence of the pseudoallergic component in the patient; Quamatel 20 ml is introduced 2 times a day, and ketotifen 1 mg is introduced 2 times a day at mealtimes. The therapeutic course is 4-6 days. That is also combined with keeping a diet avoiding high-histamine and histamine liberator food. The diet is prescribed for the whole period of treatment and 4 weeks later.

EFFECT: using the invention enables increasing the clinical effectiveness in the patients with oral mucosal paresthesia with underlying hyperacid gastritis.

2 ex